google-site-verification: googlec7193c3de77668c9.html

Study shows IL-36 gamma 'armored' CAR T cells can eradicate solid tumors

[
A laboratory study out of Roswell Park Comprehensive Cancer Center outlines a new way to boost the effectiveness of chimeric antigen receptor (CAR) T-cell therapy in solid-tumor cancers, resulting in their eradication. Led by Renier Brentjens, MD, Ph.D., Deputy Director and Chair of the Department of Medicine at Roswell Park and a pioneer in the field of CAR T-cell therapy, the research represents a hopeful new step toward achieving the same success in solid tumors that the treatment has realized in hematologic malignancies.


Source link

Advertisements

See also  A paper-based technology could transform cancer drug testing

Check Also

PRMT1 activator boosts chemotherapy in pancreatic cancer mouse study

[ The compound TR-07 (turquoise and red, in the center) can bind to the enzyme …

Gene markers quantify damage in individual kidney and liver cells

[ Graphical abstract. Credit: Cell Genomics (2026). DOI: 10.1016/j.xgen.2026.101337 Researchers at the University of Cologne, …

Tutorial unites optical brain imaging tools in a single Python framework

[ Cedalion toolbox overview and analysis workflow. (a) Functional overview of the toolbox modules. (b) …

Leave a Reply

Available for Amazon Prime